Pacira BioSciences (PCRX) Receivables - Net (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Receivables - Net of $125.6 million for Q1 2026, up 19.94% year-over-year from $104.7 million in Q1 2025, and up 1.26% quarter-over-quarter from $124.1 million in Q4 2025.
Pacira BioSciences (PCRX) Receivables - Net (2010 - 2026) Analysis & Trends
Pacira BioSciences' Receivables - Net history runs 17 years deep, the most recent figure standing at $125.6 million for Q1 2026.
- In Q1 2026, Receivables - Net rose 19.94% year-over-year to $125.6 million; the TTM figure through Mar 2026 stood at $125.6 million (up 19.94% YoY), while the FY2025 annual figure was $124.1 million, up 9.5% from the prior year.
- Receivables - Net for Q1 2026 stood at $125.6 million, up from $124.1 million in the prior quarter.
- The five-year high for Receivables - Net was $125.6 million in Q1 2026, with the low at $91.1 million in Q2 2022.
- The 5-year median for Receivables - Net is $101.6 million (2024), against an average of $104.4 million.
- The sharpest annual moves came in 2022 and 2023: Receivables - Net jumped 87.04% in 2022, then climbed 1.2% in 2023.
- Pacira BioSciences' Receivables - Net stood at $98.4 million in 2022, then gained by 7.28% to $105.6 million in 2023, then grew by 7.34% to $113.3 million in 2024, then increased by 9.5% to $124.1 million in 2025, then grew by 1.26% to $125.6 million in 2026.
- Business Quant data shows PCRX's Receivables - Net at $125.6 million in Q1 2026, $124.1 million in Q4 2025, and $115.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Pacira BioSciences | 943.54 Mn | 692.51 Mn | 148.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 132.42 Mn |
| Jun 30, 2026 | 132.42 Mn |
| Mar 31, 2026 | 125.64 Mn |
| Mar 31, 2026 | 125.64 Mn |
| Dec 31, 2025 | 124.07 Mn |
| Dec 31, 2025 | 124.07 Mn |
| Sep 30, 2025 | 115.27 Mn |
| Sep 30, 2025 | 115.27 Mn |
| Jun 30, 2025 | 114.37 Mn |
| Jun 30, 2025 | 114.37 Mn |
| Mar 31, 2025 | 104.75 Mn |
| Mar 31, 2025 | 104.75 Mn |
| Dec 31, 2024 | 113.30 Mn |
| Dec 31, 2024 | 113.30 Mn |
| Sep 30, 2024 | 100.65 Mn |
| Sep 30, 2024 | 100.65 Mn |
| Jun 30, 2024 | 104.78 Mn |
| Jun 30, 2024 | 104.78 Mn |
| Mar 31, 2024 | 101.64 Mn |
| Mar 31, 2024 | 101.64 Mn |